{
  "docId": "019de076-87a3-715f-b988-6da9cfb3fd56",
  "docSlug": "560176b410a72a6b2e67af5dd2a20758",
  "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 33 slides",
  "authorId": "neurosense-therapeutics",
  "authorName": "NeuroSense Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 33,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide outlines the methodology for a Phase 2 clinical trial for Alzheimer's Disease (AD).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-87a3-715f-b988-6da9cfb3fd56/26",
  "deckHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56",
  "deckJsonHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56.json",
  "deckAnchorHref": "/decks/019de076-87a3-715f-b988-6da9cfb3fd56#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.65,
        "x": 0.3,
        "y": 0.3
      },
      "kind": "diagram",
      "text": "1: Primary Endpoint Safety & Tolerability; 2: Secondary Efficacy Clinical Outcomes; 3: Target Engagement Biomarkers",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8bb1e257-256d-4a22-9e22-d144ce7acf5e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.12,
        "x": 0.85,
        "y": 0.02
      },
      "kind": "image",
      "text": "NeuroSense Therapeutics",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bedf8d5e-6846-4e89-af1f-a12e9c815761",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.25,
        "x": 0.07,
        "y": 0.5
      },
      "kind": "list",
      "text": "20 patients with mild to moderate AD; 1:1 PrimeC to Placebo; Cognic- intermediate formulation (=PrimeC-ER); 12-month dosing; Clinic visit every 3 months; Single-center",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e6ffd4da-f3dd-4eb7-b81d-68ed195c4c1d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.75,
        "x": 0.07,
        "y": 0.1
      },
      "kind": "title",
      "text": "Randomized, Prospective, Double-Blind, Placebo-Controlled Study",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c06e3ea8-9f9a-4533-9355-d1c7d0d46f83",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.35,
        "x": 0.07,
        "y": 0.03
      },
      "kind": "title",
      "text": "AD Phase 2 Study Design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f0ebf99c-cbe2-4035-832b-46004e41f323",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "f0dd36c2-a96c-49e5-8f65-70aeb024b077",
      "evidence": "20 patients with mild to moderate AD; 1:1 PrimeC to Placebo; Cognic- intermediate formulation (=PrimeC-ER); 12-month dosing; Clinic visit every 3 months; Single-center",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "clinical-trial-design",
      "slug": null,
      "matchId": "48d2da4f-0181-484c-8a43-ff1f7eccd7db",
      "evidence": "Standardized clinical trial methodology presentation",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}